# Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

> **NCT04420299** · PHASE2 · TERMINATED · sponsor: **Fundación de investigación HM** · enrollment: 81 (actual)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** Bemiparin
- **DRUG:** Bemiparin

## Key facts

- **NCT ID:** NCT04420299
- **Lead sponsor:** Fundación de investigación HM
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-04
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 81 (ACTUAL)
- **Why stopped:** Lack of funding of the non-commercial sponsor to extend recruitment and reach the target number of patients specified in the protocol.
- **Last updated:** 2022-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04420299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04420299, "Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04420299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*